Net Lease Office (NYSE:NLOP) Azioni

NET LEASE OFFICE PROPERTY

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.

Morgan Stanley analyst Jeffrey Hung maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Overweight and lowers the price target from $65 to $55.

News

Price Target

Analyst Ratings

RARE

Morgan Stanley Maintains Overweight on Ultragenyx Pharmaceutical, Lowers Price Target to $55

Morgan Stanley analyst Hamza Fodderwala downgrades CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from Overweight to Equal-Weight and raises the price target from $490 to $495.

Downgrades

CRWD

Morgan Stanley Downgrades CrowdStrike Holdings to Equal-Weight, Raises Price Target to $495

Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIOT#NASDAQ">VIOT</a>), a leading technology company for home water solutions in China, today announced that its board of directors has approved the declaration and distribution of a special dividend (the "Special Dividend") of US$0.0293 per ordinary share (US$0.0880 per American depositary share, or ADS). The aggregate amount of the Special Dividend will be approximately US$6 million. The Special Dividend is&nbsp;expected to be paid on or around August 18, 2025 to the holders of the Company's ordinary shares, and on or around August 21, 2025 to the holders of the Company's ADSs, of record, as of the close of business on July 31, 2025. The Special Dividend to be paid to the holders of ADSs will be subject to the terms of the deposit agreement.

Dividends

VIOT

Viomi Technology Board Approves Declaration And Distribution Of Special Dividend Of $0.0293 Per Ordinary Share

Citigroup analyst Patrick Donnelly initiates coverage on Caris Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAI#NASDAQ">CAI</a>) with a Buy rating and announces Price Target of $34.

Initiation

Citigroup Initiates Coverage On Caris Life Sciences with Buy Rating, Announces Price Target of $34

Morgan Stanley initiates coverage on Slide Insurance Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDE#NASDAQ">SLDE</a>) with a Equal-Weight rating and announces Price Target of $19.

SLDE

Morgan Stanley Initiates Coverage On Slide Insurance Holdings with Equal-Weight Rating, Announces Price Target of $19

Piper Sandler analyst James Fish maintains Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) with a Overweight and raises the price target from $121 to $140.

TWLO

Piper Sandler Maintains Overweight on Twilio, Raises Price Target to $140

Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to highlight its ongoing collaboration with Prof. Dr. med. Christian Schaaf, Director of the Institute of Human Genetics at Heidelberg University Hospital and Chairman of Human Genetics at the Medical Faculty of Heidelberg University, on a groundbreaking study investigating the neurophysiological impact of 15q13.3 copy number variants ("CNVs"). This engagement builds on prior work between Firefly and Prof. Schaaf, including a joint publication on CHRNA7-related phenotypes.1
The current study leverages Firefly's FDA-cleared technology to analyze Electroencephalograms ("EEG") data from 30 subjects — 15 with deletions and 15 with duplications of the 15q13.3 chromosomal region. Study subjects undergo resting state and two cognitive paradigms running automatically through Firefly's BNA platform.
The study is scheduled to run through 2026, with Firefly commercially engaged to provide EEG systems, training, and full analytic support, including the comparison to its proprietary, FDA-cleared normative Resting and Event-Related Potential Cognitive tasks database.
The study aims to:
<ol>
<li>Identify electrophysiological biomarkers associated with 15q13.3 CNVs;</li>
<li>Characterize neurocognitive profiles linked to deletions vs. duplications; and</li>
<li>Support future diagnostic and therapeutic strategies for neurodevelopmental disorders. &nbsp;</li>
</ol>

AIFF

Firefly Neuroscience Teams With German Hospital to Study Rare Brain Disorders Using AI and EEG

The European Union has a €21 billion ($24.52 billion) package of tariffs on U.S. goods ready for implementation should ongoing trade negotiations falter, Italy&#8217;s Foreign Minister Antonio Tajani stated in a newspaper interview on Monday, as reported by Reuters.
What Happened: This readiness comes in response to U.S. President Donald Trump&#8216;s recent threat to impose a <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46384885/peter-schiff-gives-trumps-30-tariff-threat-on-mexico-eu-a-reality-check-america-relies-on-deficits-to-make-up-for-excess-debt-and-consumption">30% tariff on imports</a> from both Mexico and the EU beginning Aug. 1, following weeks of inconclusive discussions with major trading partners. 
According to Reuters, Tajani informed the daily Il Messaggero that a second set of tariffs could follow the initial €21 billion package if a comprehensive deal with the U.S. proves unattainable.
Despite the escalating tensions, Tajani expressed confidence in the potential for progress in negotiations, emphasizing that &#8220;Tariffs hurt every one, starting with the United States.&#8221;
He further warned that declining stock markets due to tariffs would jeopardize &#8220;the pensions and the savings of the Americans,&#8221; advocating instead for a goal of &#8220;zero tariffs&#8221; and an open market spanning Canada, the United States, Mexico, and Europe.
See Also: <a href="https://www.benzinga.com/news/politics/25/07/46386524/trump-wants-blanket-tariffs-of-up-to-20-after-surprise-treasury-surplus-in-june-ed-yardeni-says-don">Trump Wants Blanket Tariffs Of Up To 20% After Surprise Treasury Surplus In June: Ed Yardeni Says &#8216;Don&#8217;t Push Your Luck&#8217;</a>
Why It Matters: In related developments, the EU announced on Sunday its decision to extend the suspension of countermeasures to U.S. tariffs until early August, aiming to continue pushing for a negotiated settlement.
Reuters also highlighted comments from German Chancellor Friedrich Merz, who on Sunday pledged to collaborate closely with French President Emmanuel Macron and European Commission President Ursula von der Leyen to de-escalate the burgeoning trade dispute.
Echoing the sentiment for a resolution, European Trade Commissioner Maros Sefcovic stated on Monday that Washington and Brussels were nearing a mutually beneficial outcome, cautioning that a 30% tariff would effectively &#8220;practically eliminate trade.&#8221;
In a Sunday post on X, Peter Schiff cautioned against Trump&#8217;s rationale for 30% tariffs, which states that reducing trade deficits with these regions signifies <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46384885/peter-schiff-gives-trumps-30-tariff-threat-on-mexico-eu-a-reality-check-america-relies-on-deficits-to-make-up-for-excess-debt-and-consumption">unfair economic arrangements</a>. 
Schiff, however, disputes this premise, contending that these deficits stem from more profound structural issues within the American economy, rather than being a consequence of disadvantageous or inequitable trade agreements. &#8220;He blames unfair trade for our deficits,&#8221; Schiff stated, further clarifying that these deficits are, in fact, &#8220;the result of excessive debt and consumption, alongside inadequate savings and investment.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Trump just threatened 30% tariffs on all Mexican and European imports starting August 1st. He blames unfair trade for our deficits. But America relies on those deficits to compensate for the consequences of excessive debt and consumption, and inadequate savings and investment.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1944041820897317042?ref_src=twsrc%5Etfw">July 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Monday. The SPY was down 0.32% at $621.60, while the QQQ declined 0.34% to $552.31, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/hedge-funds/25/07/46386374/stanley-druckenmillers-duquesne-dumps-palantir-bets-big-on-this-dividend-play-which-has-surge" target="_blank" rel="noreferrer noopener">Stanley Druckenmiller's Duquesne Dumps Palantir, Bets Big On This Dividend Play Which Has Surged Nearly 50% In 2025</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. 
Image via Shutterstock

EU Prepares $24.5B In Tariffs As Trump Threatens 30% Import Tax On Mexico, Europe

Keefe, Bruyette &amp; Woods analyst Thomas McJoynt-Griffith initiates coverage on Slide Insurance Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDE#NASDAQ">SLDE</a>) with a Market Perform rating and announces Price Target of $20.

Keefe, Bruyette & Woods Initiates Coverage On Slide Insurance Holdings with Market Perform Rating, Announces Price Target of $20

Barclays analyst Christine Cho upgrades SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from Underweight to Equal-Weight and raises the price target from $12 to $29.

Upgrades

SEDG

Barclays Upgrades SolarEdge Technologies to Equal-Weight, Raises Price Target to $29

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Piper Sandler analyst Peter Keith downgraded the rating for Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) from Overweight to Neutral and lowered the price target from $82 to $75. Best Buy shares closed at $71.79 on Friday. <a href="https://www.benzinga.com/quote/BBY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Jeff Johnson downgraded Henry Schein, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) from Outperform to Neutral and lowered the price target from $82 to $72. Henry Schein shares closed at $73.42 on Thursday. <a href="https://www.benzinga.com/quote/HSIC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Robert Ottenstein downgraded the rating for The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from Outperform to In-Line and slashed the price target from $190 to $170. Procter &amp; Gamble shares closed at $157.05 on Friday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Andrew Steinerman downgraded Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) from Neutral to Underweight but raised the price target from $5 to $6. Vestis shares closed at $6.14 on Friday. <a href="https://www.benzinga.com/quote/VSTS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Raghuram Selvaraju downgraded Verona Pharma plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) from Buy to Neutral but raised the price target from $90 to $107. Verona Pharma shares closed at $104.83 on Friday. <a href="https://www.benzinga.com/quote/VRNA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PG stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/PG/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="563" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14073747/image-153-1024x563.png" alt="" class="wp-image-983807" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14073747/image-153-1024x563.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14073747/image-153-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14073747/image-153-768x422.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14073747/image-153.png 1140w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46388321/top-3-health-care-stocks-that-could-blast-off-in-july">: </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46388321/top-3-health-care-stocks-that-could-blast-off-in-july">Top 3 Health Care Stocks That Could Blast Off In July</a></li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

HSIC

VRNA

VSTS

This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

TD Cowen analyst Robert Moskow upgrades WK Kellogg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) from Sell to Hold and raises the price target from $14 to $23.

TD Cowen Upgrades WK Kellogg to Hold, Raises Price Target to $23

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) with a Market Perform and raises the price target from $161 to $199.

Keefe, Bruyette & Woods Maintains Market Perform on PJT Partners, Raises Price Target to $199

Barclays analyst Saket Kalia downgrades Intapp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NASDAQ">INTA</a>) from Equal-Weight to Underweight and lowers the price target from $60 to $44.

INTA

Barclays Downgrades Intapp to Underweight, Lowers Price Target to $44

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) with a Market Perform and raises the price target from $46 to $57.

Keefe, Bruyette & Woods Maintains Market Perform on Lazard, Raises Price Target to $57

WIIM

FAST

Fastenal shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

Keefe, Bruyette &amp; Woods analyst Aidan Hall maintains Evercore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) with a Outperform and raises the price target from $257 to $365.

Keefe, Bruyette & Woods Maintains Outperform on Evercore, Raises Price Target to $365

KVUE

Kenvue shares are trading higher after the company appointed Kirk Perry as interim CEO and announced an ongoing review of strategic alternatives.

NBIS

Nebius Group shares are trading higher after Goldman Sachs initiated coverage with a Buy rating and announced a price target of $68.

Nokia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) has added three mobile technology tools to Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google Cloud Marketplace, making it easier for developers worldwide to use them when building apps.
These tools, Quality of Service on Demand, Number Verification, and Device Location Verification, help apps run better and more securely <a target="_blank" href="https://www.nokia.com/newsroom/nokia-network-apis-now-available-on-google-cloud-marketplace-making-it-even-easier-for-developers-to-utilize/" rel="noreferrer noopener">on mobile networks</a>.
By putting these tools on Google Cloud, Nokia gives developers a simple way to access advanced mobile features without needing deep technical knowledge of how networks work. Developers can now more efficiently build apps that work across multiple mobile networks.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/46134725/google-cloud-hires-former-oracle-cfo-as-ai-race-heats-up" rel="noreferrer noopener">Google Cloud Hires Former Oracle CFO As AI Race Heats Up</a>
These tools are part of Nokia&#8217;s effort to make mobile networks more open and usable for app creators. They follow global standards so that apps using them can work smoothly in different countries. Nokia plans to bring even more of these tools to Google Cloud.
Global cloud infrastructure spending hit $90.9 billion in the first quarter of 2025, rising 21% year-over-year as enterprises ramped up cloud migration to support AI deployment, <a target="_blank" href="https://canalys.com/newsroom/global-cloud-q1-2025" rel="noreferrer noopener">per</a> Canalys. Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services (AWS), Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Azure, and Google Cloud held their lead, commanding 65% of global market share and growing a combined 24% from the prior year.
Microsoft Azure and Google Cloud saw growth above 30%, while AWS&#8217;s growth slowed to 17%, down from 19% in the fourth quarter, due to supply constraints that limited its ability to meet soaring AI demand. Leading cloud providers invest in AI infrastructure to stay competitive and reduce AI costs, primarily proprietary chips that improve efficiency and scale inference workloads.
Generative AI remains a key driver, pushing businesses to accelerate cloud adoption and migrate more workloads off legacy systems. In 2025, cloud and AI infrastructure will cement the market&#8217;s core growth themes.
Price Action: GOOGL stock is trading lower by 0.51% to $179.28 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46090025/verizon-teams-up-with-nokia-to-bring-high-tech-5g-boost-to-busy-british-ports" target="_blank" rel="noreferrer noopener">Verizon Teams Up With Nokia To Bring High-Tech 5G Boost To Busy British Ports</a></li>
</ul>
Photo via Shutterstock

Comments

Net Lease Office

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO